Cargando…
Hereditary Endocrine Tumor Registries
CONTEXT: Endocrine neoplasia syndromes are phenotypically complex, and there is a misconception that they are universally rare. Genetic alterations are increasingly recognized; however, true prevalence is unknown. The purpose of a clinical registry is to monitor the quality of health care delivered...
Autores principales: | Moore, Edwina C, Ioannou, Liane, Ruseckaite, Rasa, Serpell, Jonathan, Ahern, Susannah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825730/ https://www.ncbi.nlm.nih.gov/pubmed/36632485 http://dx.doi.org/10.1210/jendso/bvac194 |
Ejemplares similares
-
Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry
por: Ratnayake, Irushi, et al.
Publicado: (2021) -
Response rates in clinical quality registries and databases that collect patient reported outcome measures: a scoping review
por: Ruseckaite, Rasa, et al.
Publicado: (2023) -
Informing a national rare disease registry strategy in Australia: a mixed methods study
por: Ruseckaite, Rasa, et al.
Publicado: (2023) -
Developing a Preliminary Conceptual Framework for Guidelines on Inclusion of Patient Reported-Outcome Measures (PROMs) in Clinical Quality Registries
por: Ruseckaite, Rasa, et al.
Publicado: (2019) -
Current state of rare disease registries and databases in Australia: a scoping review
por: Ruseckaite, Rasa, et al.
Publicado: (2023)